Response to antiviral therapy predicts the development of glucose abnormalities in patients with chronic HCV genotype 4 infection

被引：0
|
作者：
Chehadeh, W. [1 ]
Al-Nakib, W. [1 ]
机构：
[1] Kuwait Univ, Fac Med, Dept Microbiol, Virol Unit, Kuwait, Kuwait
来源：
JOURNAL OF CLINICAL VIROLOGY | 2009年 / 46卷
关键词：
D O I：
10.1016/S1386-6532(09)70153-2
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [41] Ombitasvir/Paritaprevir/Ritonavir: A Review in Chronic HCV Genotype 4 Infection
    Keating, Gillian M.
    DRUGS, 2016, 76 (12) : 1203 - 1211
  • [42] The Impact of Antiviral Therapy and the Influence of Metabolic Cofactors on the Outcome of Chronic HCV Infection
    Persico, Marcello
    Bruno, Savino
    Costantino, Andrea
    Mazza, Marta
    Almasio, Piero Luigi
    INTERNATIONAL JOURNAL OF HEPATOLOGY, 2011, 2011
  • [43] Outcome of antiviral therapy in Egyptian Hepatitis C Virus (HCV) genotype 4 patients with advanced liver fibrosis
    El Khattib, Ahmed A.
    Abdelhakam, Sara M.
    Ghoraba, Dalia M.
    Ibrahim, Wesam A.
    Sayed, Moataz M.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (01) : E34 - E35
  • [44] Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy
    Deneke, M. G.
    Dranoff, J. A.
    Duarte-Rojo, A.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2014, 79 (01): : 64 - 66
  • [45] THE EFFECT OF SUSTAINED VIROLOGIC RESPONSE ON CEREBRAL METABOLISM AND NEUROCOGNITION IN PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION
    Curry, M. P.
    Moczynski, N. P.
    Liu, L.
    Stamm, L.
    Yun, C.
    Brainard, D. M.
    McHutchison, J. G.
    Alsop, D.
    Afdhal, N. H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S797 - S797
  • [46] IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4
    Antaki, N.
    Bibert, S.
    Kebbewar, K.
    Asaad, F.
    Baroudi, O.
    Alideeb, S.
    Hadad, M.
    Abboud, D.
    Sabah, H.
    Bochud, P. -Y.
    Negro, F.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (01) : 59 - 64
  • [47] Therapeutic response in children with post malignancy chronic HCV genotype 1 infection
    Urganci, Nafiye
    Gulec, Seda Geylani
    Polat, Tugcin Bora
    Vural, Sema
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2009, 44 (02): : 68 - 72
  • [48] Rheumatoid factor after antiviral therapy in patients with HCV chronic hepatitis
    Riccio, A.
    Conca, P.
    Marzocchella, C.
    Tarantino, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (05) : 926 - 928
  • [49] THE NOVEL ss469415590 POLYMORPHISM PREDICTS RESPONSE TO ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS TYPE 1 INFECTION
    Covolo, L.
    Bibert, S.
    Donato, F.
    Bochud, P. -Y.
    Lagging, M.
    Negro, F.
    Fattovich, G.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S476 - S476
  • [50] Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4
    Rizk, Hanan H.
    Hamdy, Nadia M.
    Al-Ansari, Nadia L.
    El-Mesallamy, Hala O.
    PLOS ONE, 2016, 11 (04):
12345